EUVIMEDEUVIMED entdecken
Open Access

Antibodies to Tick Salivary Antigens AV422 and Calreticulin in Patients With Spotted Fever Group Rickettsioses and Other Febrile Illnesses in Northern Tanzania

Ganga S Moorthy iD, Bessie H Blocher iD, Deng B Madut iD, Halie K Miller iD, Jamie L Perniciaro iD, Jo E B Halliday iD, Blandina T Mmbaga iD, Bingileki F Lwezaula iD, Sarah Cleaveland iD, Venance P Maro iD, John A Crump iD, William L Nicholson und 1 weitere

The Journal of Infectious Diseases · 2026

DOI: 10.1093/infdis/jiaf506 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2026. Verfasst von Ganga S Moorthy und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Infectious Diseases, Duke University Medical Center, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Calreticulin, Spotted Fever Group Rickettsiosis, Antibodies, Bacterial, Salivary Proteins and Peptides. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, FIC NIH HHS, US National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Timely and accurate diagnosis of spotted fever rickettsioses (SFR) is difficult due to nonspecific symptoms and testing challenges. We evaluated serum antibodies to the tick salivary proteins AV422 and calreticulin as potential markers of recent tick exposure in febrile patients from northern Tanzania.

Methods

We recruited febrile patients at 2 hospitals in Moshi, Tanzania, from February 2012 through May 2014. Acute and convalescent sera from enrolled participants were tested against Rickettsia africae antigen using indirect immunofluorescence assays (IFAs). Participants with ≥4-fold rise in R africae IFA immunoglobulin G reciprocal titer between sera were classified as cases (n = 70), those with paired sera with reciprocal titer ≥64 but no ≥4-fold rise as exposed (n = 40), and participants with reciprocal titer <32 in either sera as unexposed (n = 38). Acute and convalescent sera were tested for calreticulin and AV422 antibodies using enzyme-linked immunosorbent assay.

Results

We found significantly higher calreticulin antibody levels in acute sera of cases compared to exposed, unexposed, and the combined comparator of exposed and unexposed (adjusted mean difference [95% confidence interval {CI}], 17.49 [6.37–28.61]; 17.61 [6.55–28.67]; and 18.11 [9.13–27.10], respectively). Calreticulin distinguished cases from exposed and unexposed among persons 0–15 years old with positive predictive value of 0.77 (95% CI, .61–.88) and sensitivity of 0.94 (95% CI, .81–.99).

Conclusions

In the acute phase of febrile illness, measurement of calreticulin antibody, a proposed marker for tick exposure, was higher in patients with confirmed tick-borne illness and had reasonable diagnostic test characteristics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CalreticulinSpotted Fever Group RickettsiosisAntibodies, BacterialSalivary Proteins and PeptidesTicksFeverHumansTanzaniaFemaleMaleAdultAdolescentAnimalsYoung AdultChildMiddle AgedChild, PreschoolImmunoglobulin GAgedEnzyme-Linked Immunosorbent AssayFluorescent Antibody Technique, Indirect

Stichwörter der Autor:innen

RickettsiaEast Africaenzyme-linked immunosorbent assayspotted fever group rickettsiosestick-borne diseases

Substanzen

CalreticulinAntibodies, BacterialSalivary Proteins and PeptidesImmunoglobulin G

Autor:innen und Institutionen

  • Division of Pediatric Infectious Diseases, Duke University Medical Center, Durham, North Carolina, USA.
  • Duke Global Health Institute, Duke University, Durham, North Carolina, USA.
  • Rickettsial Zoonoses Branch, Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Division of Infectious Diseases and International Health, Duke University Medical Center, Durham, North Carolina, USA.
  • School of Biodiversity, One Health and Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
  • KCMC University, Moshi, Tanzania.

ORCID-Profile: Ganga S Moorthy, Bessie H Blocher, Deng B Madut, Halie K Miller, Jamie L Perniciaro, Jo E B Halliday, Blandina T Mmbaga, Bingileki F Lwezaula, Sarah Cleaveland, Venance P Maro, John A Crump, Matthew P Rubach

Förderung

  • NIAID NIH HHS
  • FIC NIH HHS
  • US National Institutes of Health
  • Research Councils UK
  • Department for International Development
  • Biotechnology and Biological Sciences Research Council
  • Gates Foundation
  • NIH

Zitieren

APA

Moorthy, G. S., Blocher, B. H., Madut, D. B., Miller, H. K., Perniciaro, J. L., Halliday, J. E. B., Mmbaga, B. T., Lwezaula, B. F., Cleaveland, S., Maro, V. P., Crump, J. A., Nicholson, W. L., & Rubach, M. P. (2026). Antibodies to Tick Salivary Antigens AV422 and Calreticulin in Patients With Spotted Fever Group Rickettsioses and Other Febrile Illnesses in Northern Tanzania. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf506

Vancouver

Moorthy GS, Blocher BH, Madut DB, Miller HK, Perniciaro JL, Halliday JEB, et al. Antibodies to Tick Salivary Antigens AV422 and Calreticulin in Patients With Spotted Fever Group Rickettsioses and Other Febrile Illnesses in Northern Tanzania. The Journal of Infectious Diseases. 2026. doi:10.1093/infdis/jiaf506

BibTeX
@article{Moorthy2026,
  author = {Moorthy, Ganga S and Blocher, Bessie H and Madut, Deng B and Miller, Halie K and Perniciaro, Jamie L and Halliday, Jo E B and Mmbaga, Blandina T and Lwezaula, Bingileki F and Cleaveland, Sarah and Maro, Venance P and Crump, John A and Nicholson, William L and Rubach, Matthew P},
  title = {Antibodies to Tick Salivary Antigens AV422 and Calreticulin in Patients With Spotted Fever Group Rickettsioses and Other Febrile Illnesses in Northern Tanzania},
  journal = {The Journal of Infectious Diseases},
  year = {2026},
  doi = {10.1093/infdis/jiaf506}
}
Kostenlos starten →